Kiang-Teck Jerry Yeo to Genotype
This is a "connection" page, showing publications Kiang-Teck Jerry Yeo has written about Genotype.
Connection Strength
0.454
-
Comparison of performance of three commercial platforms for warfarin sensitivity genotyping. Clin Chim Acta. 2009 Aug; 406(1-2):143-7.
Score: 0.238
-
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation. Clin Chem. 2007 May; 53(5):823-8.
Score: 0.051
-
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clin Chim Acta. 2006 May; 367(1-2):196-200.
Score: 0.047
-
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer. 2022 Apr 15; 128(8):1649-1657.
Score: 0.036
-
Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform. J Appl Lab Med. 2021 11 01; 6(6):1505-1516.
Score: 0.035
-
Pharmacogenomic-Based Decision Support to Predict Adherence to Medications. Clin Pharmacol Ther. 2020 08; 108(2):368-376.
Score: 0.032
-
Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project. J Mol Diagn. 2010 Nov; 12(6):835-46.
Score: 0.016